Prevalence of dermatologic manifestations of COVID-19 disease is estimated between 0.25 % and 3% in children and adolescents. In this review article, we decided to describe cutaneous and histopathological manifestations […]
Read More
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
